Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pranamee, Sarma"'
Autor:
Willemijn S M E Theelen, Thomas Kuilman, Katja Schulze, Wei Zou, Oscar Krijgsman, Dennis D G C Peters, Sten Cornelissen, Kim Monkhorst, Pranamee Sarma, Teiko Sumiyoshi, Lukas C Amler, Stefan M Willems, Johannes L G Blaauwgeers, Carel J M van Noesel, Daniel S Peeper, Michel M van den Heuvel, Marcin Kowanetz
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0216864 (2019)
BackgroundIn non-small cell lung cancer (NSCLC), PD-L1 expression on either tumor cells (TC) or both TC and tumor-infiltrating immune cells (IC) is currently the most used biomarker in cancer immunotherapy. However, the mechanisms involved in PD-L1 r
Externí odkaz:
https://doaj.org/article/71ec07804c5045b0afac420650e42855
Autor:
Thomas Kuilman, Johannes L. G. Blaauwgeers, Dennis Peters, Sten Cornelissen, Marcin Kowanetz, Lukas C. Amler, Kim Monkhorst, Willemijn S. M. E. Theelen, Oscar Krijgsman, Stefan M. Willems, Daniel S. Peeper, Pranamee Sarma, Carel J. M. van Noesel, Wei Zou, Katja Schulze, Teiko Sumiyoshi, Michel M van den Heuvel
Publikováno v:
PLoS One, 14, 5
PLoS ONE, 14(5):e0216864. Public Library of Science
PLoS One, 14
PLoS ONE, 14(5). Public Library of Science
PLoS ONE, Vol 14, Iss 5, p e0216864 (2019)
PLoS ONE
PLoS ONE, 14(5):e0216864. Public Library of Science
PLoS One, 14
PLoS ONE, 14(5). Public Library of Science
PLoS ONE, Vol 14, Iss 5, p e0216864 (2019)
PLoS ONE
BackgroundIn non-small cell lung cancer (NSCLC), PD-L1 expression on either tumor cells (TC) or both TC and tumor-infiltrating immune cells (IC) is currently the most used biomarker in cancer immunotherapy. However, the mechanisms involved in PD-L1 r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c9e935a597303c8ca691ca860f905c
https://hdl.handle.net/2066/204229
https://hdl.handle.net/2066/204229
Autor:
Pranamee Sarma, Esther Martinez-Martinez, Ramesh Gujjar, Pierre-Yves Desprez, Mukkanti Amere, Jonathon Judkins, Eiman Elwakeel, Sean D. McAllister, Rumi Kawamura, Ryuichi Murase, Eric Singer, Anu Mahadevan, Sonali Dayal, Arash Pakdel
Publikováno v:
British Journal of Pharmacology. 171:4464-4477
Background and Purpose The psychoactive cannabinoid Δ9-tetrahydrocannabinol (THC) and the non-psychoactive cannabinoid cannabidiol (CBD) can both reduce cancer progression, each through distinct anti-tumour pathways. Our goal was to discover a compo
Autor:
Ryuichi, Murase, Rumi, Kawamura, Eric, Singer, Arash, Pakdel, Pranamee, Sarma, Jonathon, Judkins, Eiman, Elwakeel, Sonali, Dayal, Esther, Martinez-Martinez, Mukkanti, Amere, Ramesh, Gujjar, Anu, Mahadevan, Pierre-Yves, Desprez, Sean D, McAllister
Publikováno v:
British journal of pharmacology. 171(19)
The psychoactive cannabinoid Δ(9) -tetrahydrocannabinol (THC) and the non-psychoactive cannabinoid cannabidiol (CBD) can both reduce cancer progression, each through distinct anti-tumour pathways. Our goal was to discover a compound that could effic